Inherited Thromophilia and Thrombotic Risks in Inflammatory Bowel Disease During Activity and Remission

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

93 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-11-30

Study Completion Date

2027-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Inherited thombopllia and thrombotic risks in inflammatory bowel Disease during activity and remission

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Coagulation Parameters in IBD Patients

NCT04115722

Coagulopathy

UNKNOWN

Arterial Thrombosis and Inflammatory Bowel Disease: a Series of 6 Cases and Literature Review

NCT02896530

Arterial Thrombosis

COMPLETED

Renal Involvement in Adult Patients with Inflammatory Bowel Disease and Its Relation to Duration and Disease Activity

NCT06717516

IBD and Renal Involement IBD Activity and Kidney Affection

NOT_YET_RECRUITING

Thrombin Generation in Crohn's Disease

NCT02445690

Crohn Disease Blood Clot Thrombosis

UNKNOWN

Evaluation of Blood Platelet Indices,Platelet Aggregation in the Activity of IBD Patients on Biological Treatment

NCT05406934

Bowel Disease Inflammatory Bowel Diseases

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Inflammatory bowel diseases (IBD) are systemic conditions characterized by multiple intestinal and extra-intestinal manifestations related to the associated chronic inflammatory state. Among their diverse extra-intestinal complications, venous thromboembolism (VTE) remains one of the most under recognized causes of morbidity and mortality in these patients, highlighting the need for a better understanding of the underlying mechanism of hypercoagulability, in addition to the role of acquired and inherited risk factors that further increase the risk of thrombosis with its impact on patients' outcomes.\[1, 2\]

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inflammatory Bowel Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age (18yrs - 65yrs) both sex

Exclusion Criteria

* Presence of acquired cause (pregnancy, recent surgery, history of drug, History of malignant Disease, History of blood or blood product transfusion in last 4 weeks)

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No